A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

Author： O’Connor R.   O’Leary M.   Ballot J.   Collins C.   Kinsella P.   Mager D.   Arnold R.   O’Driscoll L.   Larkin A.   Kennedy S.   Fennelly D.   Clynes M.   Crown J.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.1, 2007-01, pp. : 79-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer

By Cohen Steven   Gallo James   Lewis Nancy   Alpaugh R.   Gentner Louis   Rogatko André   Yeslow Gwen   Schol Jessie   Verhaeghe Tom   Zannikos Peter   Palmer Peter   Weiner Louis   Meropol Neal  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 6, 2004-06 ,pp. : 513-518

Springer Publishing Company

Access to resources Recommend Favorite

Multidrug Resistance Mediated by MRP1 Gene Overexpression in Breast Cancer Patients

By Abaan Ogan Demir   Mutlu Pelin Kaya   Baran Yusuf   Atalay Can   Gunduz Ufuk  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 201-205

Informa Healthcare

Access to resources Recommend Favorite

A Phase I Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer

By Kimura Yutaka   Yano Hiroshi   Imamura Hiroshi   Fujitani Kazumasa   Imano Motohiro   Tokunaga Yukihiko   Matsuoka Masaki   Kurokawa Yukinori   Shimokawa Toshio   Takiuchi Hiroya   Tsujinaka Toshimasa   Furukawa Hiroshi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 125-131

Oxford University Press

Access to resources Recommend Favorite

A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer

By Hokita Shuichi   Aikou Takashi   Miyazono Futoshi   Ishigami Sumiya   Aridome Kuniaki   Maenohara Shigeho   Saihara Tetsushi   Suenaga Kuniaki   Nomura Hidehiro   Maeda Satoshi   Takatori Hiroyuki   Arima Hideo   Uchikado Yasuto   Natsugoe Shoji   Takao Sonshin  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 736-740

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer

By Shiozawa Manabu   Sugano Nobuhiro   Tsuchida Kazuhito   Morinaga Soichiro   Akaike Makoto   Sugimasa Yukio  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 3, 2009-03 ,pp. : 365-370

Springer Publishing Company

Access to resources Recommend Favorite